Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$51,223,462
+$4,011,344 QoQ
Shares Held
201,691
+4.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#440
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Dec 31, 2024CallValue
$173,544,000
CallShares
1,200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aptus Capital Advisors, LLC holds $223,621,682 across 14 Drug Manufacturers - General names. JNJ ranks #2 (22.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
53,662 | $64,363,817 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
201,691 | $51,223,462 | |
| 3 | ABBV |
AbbVie Inc.
|
142,030 | $35,740,429 | |
| 4 | MRK |
Merck & Co., Inc.
|
201,987 | $25,955,329 | |
| 5 | AMGN |
Amgen Inc
|
42,764 | $15,485,699 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
74,929 | $9,466,529 | |
| 7 | PFE |
Pfizer Inc
|
365,411 | $8,799,096 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
134,318 | $7,739,403 |
All Filings in JNJ
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,223,462 | 201,691 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $47,212,118 | 193,144 | Shares | Other | 2026-05-11 | |
| 2025-12-31 | $41,229,613 | 199,225 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $30,481,934 | 164,394 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $24,819,431 | 162,484 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $25,954,954 | 156,506 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $173,544,000 | 1,200,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $24,478,235 | 169,259 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $23,751,998 | 146,563 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $15,274,304 | 104,504 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $13,388,094 | 84,633 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $11,635,436 | 74,234 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $12,862,302 | 82,583 | Shares | Other | 2023-11-08 | |
| 2023-06-30 | $13,115,473 | 79,238 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $12,936,455 | 83,461 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $15,672,034 | 88,718 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $12,660,399 | 77,500 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $12,838,054 | 72,323 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $11,744,854 | 66,269 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $9,550,666 | 55,829 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $8,661,406 | 53,631 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $7,674,083 | 46,583 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $6,918,969 | 42,099 | Shares | Other | 2021-05-06 | |
| 2020-12-31 | $7,422,040 | 47,160 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $6,055,694 | 40,675 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $5,341,971 | 37,986 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $5,037,490 | 38,416 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||